HomeEXECUTIVESAllan May Has Been Appointed Chairman of FundamentalVR - Respected and Established Figure in Silicon Valley

Allan May Has Been Appointed Chairman of FundamentalVR – Respected and Established Figure in Silicon Valley

September 23, 2020

Allan May has been appointed Chairman of FundamentalVR. The news was announced today.

Allan May is a renowned Medtech pioneer. May will lead the company’s continued growth in the United States and scale its surgical education and data insight platform, Fundamental Surgery. He will also establish a west coast office for the company.

A highly respected and established figure in Silicon Valley, Allan May joins FundamentalVR as Chairman with decades of experience in funding, leading, and co-founding companies across biotech, Medtech, and diagnostics. He is the founder of Life Science Angels, a Bay Area early-stage investment group that has invested over $70 million in more than 70 biotech, medical device, diagnostics, and mobile health companies. He is also a Venture Partner at Medtech Convergence Fund, a $90 million seed, and an early-stage venture capital fund. May will continue his work with Life Science Angels and Medtech Convergence Fund while serving as Chairman at FundamentalVR.

In 2007, May co-founded Emergent Medical Partners, a venture fund focused on early-stage medical device companies that have invested $70 million in more than 30 startups. For the last 25 years, May has served as founder, Chairman, or CEO at ten startup medical device and diagnostic companies. He has also been an investor in over 65 Medtech, biotech, and diagnostic startups. Recent companies he has co-founded include Nanostim, a developer of the first Leadless Cardiac Pacemaker, and Hyalex Surgical, a company that creates synthetic cartilage for total joints.

Established in 2015, FundamentalVR develops bespoke immersive training simulations for medical device and pharmaceutical companies and serves medical institutions and teaching hospitals through its device-agnostic Fundamental Surgery platform. In 2019, it completed a series A funding round, which included participation from two leading medical institutions – Mayo Clinic, one of America’s leading centers of medical excellence, and Sana Kliniken, the third-largest hospital organization in Germany.

 

“We are thrilled to have Allan May join FundamentalVR as Chairman and look forward to working with him during this time where we have seen interest and adoption of immersive medical technology skyrocketing during COVID,’’ said Richard Vincent, co-founder and CEO of FundamentalVR. “Allan has the experience to help us scale quickly and ensure that all surgeons, residents, and trainees around the world have access to safe and affordable training methods.”

Named as one of the best inventions of 2018 by Time magazine and 2019 winners of the SXSW Innovation Award for VR/AR & MR, Fundamental Surgery’s multimodal, multiuser platform was launched in August 2018. Its HapticVRTM modality combines virtual reality with cutting-edge haptics to create a scalable ‘flight simulator’ experience for trainees and qualified surgeons, allowing them to experience and navigate the same visuals, sounds, and feelings they would during an actual surgical procedure.

Its @HomeVR modality brings Fundamental Surgery’s educational simulations to standalone VR headsets such as Oculus Quest and HTC Vive Focus Plus. It complements the gold standard education capabilities of the HapticVR™ modality and expands the platform to provide even more flexible and cost-effective learning opportunities.

Fundamental Surgery simulations have been accredited by the American Academy of Orthopaedic Surgeons and the Royal College of Surgeons of England, allowing the use of either modality to count towards a surgeons’ ongoing professional development. It can be seen in action here.

“The combination of massive economic dislocation and social distancing brought on by COVID-19 are proving the forces needed to drive permanent change in surgical training and testing as well as the marketing and adoption of new medical devices,” commented May. “FundamentalVR are market leaders in surgical AR/VR technology. The combination of its haptics, multi-user capabilities, sophisticated use cases and applications will allow the company to dominate U.S. surgical training as it is uniquely positioned to provide the proficiency tools and metrics needed to lower the learning curve for trainee and qualified surgeons.”

Created by a team of VR, haptic specialists, and surgical training experts, FundamentalVR has created multiple customized enterprise solutions covering a wide variety of procedures for medical device and pharmaceutical companies, including Pacira and Boston Scientific. Its Fundamental Surgery platform is deployed with medical institutions worldwide, including Mayo Clinic and UCLA in the U.S., UCLH in the U.K., and Sana Kliniken in Germany.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

Jonathan Chapman: New President/CEO of Trividia Health

Chapman said, “I’m honored to join the Trividia team as President and CEO. This organization has a long history of leadership within the healthcare industry as a provider of accurate, accessible, and affordable point-of-care solutions for the management of diabetes.”

Skyhawk Therapeutics Completes New Investment Round

A $133 million round of investment will allow Skyhawk to accelerate development of its novel small molecule RNA-modifying drug candidates into the clinic.

By using this website you agree to accept Medical Device News Magazine Privacy Policy